Reuters
Health - Reuters

File photo illustration of pills of all kinds, shapes and colours, March 2003. (Jacky Naegelen/Reuters)

Vitamin D may lower breast cancer risk

Thu May 15, 9:25 PM ET

WASHINGTON (Reuters) - Breast cancer patients with lower levels of vitamin D were far more likely to die and far more likely to have their cancer spread than women with normal levels, Canadian researchers reported on Thursday.

  • A cancer patient is seen through the tube of a magnetic resonance imaging scanner at Georgetown University Hospital in Washington May 23, 2007. (Jim Bourg/Reuters)
    New scans prompt mastectomies for breast patients Thu May 15, 9:30 PM ET

    WASHINGTON (Reuters) - Breast cancer patients who get newer scans called magnetic resonance imaging are more likely to opt for mastectomies, U.S. researchers reported on Thursday.

  • An Ukrainian boy suffering from cancer wears a mask in a children's hospital in Kiev April 4, 2006. (Damir Sagolj/Reuters)
    Heart risks high in childhood cancer survivors Thu May 15, 9:27 PM ET

    CHICAGO (Reuters) - Children who survive cancer while they are young are five to 10 times more likely than their healthy siblings to develop heart disease, U.S. researchers said on Thursday.

  • Obesity contributes to global warming: study Thu May 15, 7:03 PM ET

    GENEVA (Reuters) - Obesity contributes to global warming, too.

  • Bone drugs seen helping fight cancer spread Thu May 15, 9:31 PM ET

    WASHINGTON (Reuters) - A drug prescribed to prevent fractures in breast cancer patients whose tumors have spread may actually help slow the cancer itself, U.S. researchers reported on Thursday.

  • Boxes of the contraceptive Postinor-2, known as the 'morning-after pill', are seen inside a safe in a public health clinic in Santiago September 22, 2006. (Ivan Alvarado/Reuters)
    Morning-after pill sold over the counter in Canada Thu May 15, 4:47 PM ET

    TORONTO (Reuters) - The so-called "morning after" pill Plan B has received full over-the-counter status in Canada, drug maker Paladin Labs Inc said on Thursday.

  • Myanmar residents queue to get drinking water in Yangon on May 5. The World Health Organisation has warned that victims of the devastating cyclone are at risk from cholera, malaria and diarrhea due to a lack of safe drinking water.(AFP/File/Khin Maung Win)
    Some cholera confirmed in cyclone-hit Myanmar 52 minutes ago

    BANGKOK (Reuters) - An international aid agency has confirmed some cases of cholera in Myanmar's cyclone-hit Irawaddy delta but the number was in line with normal levels in previous years, an aid official said on Friday.

  • Canada scraps new medical reactor, isotopes safe 54 minutes ago

    OTTAWA (Reuters) - Canada said on Friday it was scrapping work on a trouble-plagued nuclear reactor designed to produce medical isotopes but vowed to maintain output by continuing to use an older reactor.

  • Pedestrians wait to walk across a street near Times Square in New York August 28, 2007. (Lucas Jackson/Reuters)
    Obesity tied to risk of psychiatric disorders Thu May 15, 1:04 PM ET

    NEW YORK (Reuters Health) - Obesity is a well known risk factor for certain physical health problems, but a new study suggests that heavy adults also have higher rates of psychiatric disorders.

  • A syringe is filled with Merck  and  Co's vaccine Zostavax in an undated handout photo, released to Reuters on May 15, 2008. (Merck  and  Co./Handout/Reuters)
    CDC recommends shingles vaccine for age 60 and up Thu May 15, 2:12 PM ET

    WASHINGTON (Reuters) - U.S. health officials on Thursday recommended that people 60 and older get Merck & Co Inc's vaccine Zostavax to protect against shingles, a viral infection that causes a painful, blistering rash.

  • Avastin improves brain cancer survival Thu May 15, 10:24 PM ET

    LOS ANGELES (Reuters) - Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.

  • Study shows RAD001 froze kidney cancer for a year Thu May 15, 9:23 PM ET

    WASHINGTON (Reuters) - Nearly two-thirds of kidney cancer patients taking Novartis AG's RAD001 had progression of their disease delayed by a year, a significantly better result than in those taking placebo, investigators said.

  • Competitive eater 'Crazy Legs Conti' tries to eat his weight in popcorn as a stunt to promote a documentary film about himself in New York, May 3, 2004. (Chip East/Reuters)
    Popcorn fans eat more whole grain: study Thu May 15, 2:13 PM ET

    NEW YORK (Reuters Health) - People who snack on popcorn may consume more whole grains and less meat than their peers who don't, new research shows.

  • Lung cancer patients live longer with Alimta: study Thu May 15, 9:26 PM ET

    WASHINGTON (Reuters) - Lung cancer patients who took Eli Lilly and Co's Alimta after finishing their normal course of chemotherapy lived 40 percent longer without any tumor progression than patients who took a placebo, researchers reported on Thursday.

  • Drug ad effects on people need more study: FDA Thu May 15, 6:15 PM ET

    ROCKVILLE, Maryland (Reuters) - Ads for prescription drugs need to be clear and direct and government needs to study the effects these ads have on consumer behavior, particularly among the elderly and minorities, a U.S. Food and Drug Administration panel of outside experts said on Thursday.

  • Salmonella outbreak traced to tainted dog food Thu May 15, 3:05 PM ET

    NEW YORK (Reuters Health) - Contaminated dry dog food was the source of an outbreak of Salmonella infections affecting people in 19 states, public health officials report in the Morbidity and Mortality Weekly Report, a publication of the U.S. Centers for Disease Control and Prevention.

  • Ankle sprains cause lasting problems for some Thu May 15, 2:14 PM ET

    NEW YORK (Reuters Health) - While many people who sprain an ankle get back on their feet quickly, some continue to have pain and other problems for months to years, a new study shows.

  • J&J recalling certain lots of drugs after theft Thu May 15, 2:59 PM ET

    NEW YORK (Reuters) - Johnson & Johnson said on Thursday it was voluntarily recalling specific lots of three of its medicines to protect patients from receiving potentially mishandled or damaged products after a truck carrying the drugs was stolen.

  • Nerve block cuts hot flashes after breast cancer Thu May 15, 1:06 PM ET

    NEW YORK (Reuters Health) - Blocking parts of the nervous system that regulate body temperature can reduce hot flashes and improve sleep in survivors of breast cancer, researchers reported on Thursday.

  • Some statins may protect against cancer: study Thu May 15, 1:01 PM ET

    NEW YORK (Reuters Health) - High-doses of cholesterol-lowering statins that are "lipophilic" -- meaning they are soluble in fats -- may offer protection against cancer, according to a new study that found a significant reduction in the incidence of cancer in users of these statins.